CHEPLAPHARM ARZNEIMITTEL GMBH
502074-9890ActiveGlobal platform acquiring and developing established specialty pharmaceutical brands.
Yleiskatsaus
- 0
- Työntekijät
- 100–500milj SEK
- Liikevaihto
- 2014
- Perustettu
Avainpäättäjät
Artem Gevorkyan
Senior Vice President Corporate Business Development
Sebastian Braun
Chief Executive Officer
Caroline Jacquin
Managing Director France
Keyarasch Parssanedjad
Chief Financial Officer
+14 lisää yhteystietoja Funnelfeedrissä
Kuvaus
CHEPLAPHARM Arzneimittel GmbH is a globally active company headquartered in Germany, dedicated to building a sustainable platform for Specialty Pharma. Their core business involves investing in and carefully developing long-established, trusted branded pharmaceutical products acquired from research-...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Utländsk juridisk person
- ALV-numero
- SE502074989001
Päättäjät
18 yhteystietoa FunnelfeedrissäArtem Gevorkyan
Senior Vice President Corporate Business Development
Sebastian Braun
Chief Executive Officer
Caroline Jacquin
Managing Director France
Keyarasch Parssanedjad
Chief Financial Officer
Edeltraud M. Lafer
Co-Chief Executive Officer
Sandra Schröder
Vice President Scientific
Dr. Markus Peterseim
Chief Technology Officer
Klaus Köhl
Chief Operating Officer
Urška Škof Bušs
Vice President Global Integrations & Separations
Dr. Kia Parssanedjad
Chief Financial Officer
Tamás Szóga
Vice President Commercial
Karl "Charly" Lang
Vice President Supply Chain Logistics
Bianca Y. Juha
Chief Scientific Officer
Fabian Kunick
Senior Director Treasury & Investor Relations
Stephanie Lemke
Senior Investor Relations Manager
Pierre Lüders
Head of Compliance, Export Control & Data Protection
Muut yhteyshenkilöt
Fabian Franke
Head of Investor Relations
Anna Rautenberg
Senior Specialist Compliance
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäINFECTOPHARM ARZNEIMITTEL UND CONSILIUM GMBH
0 työntekijätFamily-owned German pharmaceutical company specializing in innovative medicines.
Immedica Pharma AB
50–99 työntekijätCommercializing rare disease medicines globally through strategic partnerships.
Santhera Pharmaceuticals (Sweden) AB
1–4 työntekijätSwiss specialty pharma developing treatments for rare neuromuscular diseases.
Immedica Bidco AB
1–4 työntekijätCommercializing rare disease medicines globally through strategic partnerships.
INFECTOPHARM ARZEIMITTEL UND CONSILIUM GMBH
Family-owned firm developing innovative, patient-centered established medications.
Kysymyksiä yrityksestä CHEPLAPHARM ARZNEIMITTEL GMBH
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo